3,4-methylenedioxyamphetamine has been researched along with Brain Neoplasms in 1 studies
3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Kaye, EC | 1 |
Kegel, A | 1 |
Weber, M | 1 |
Cartwright, C | 1 |
Spraker-Perlman, H | 1 |
Robinson, GW | 1 |
Baker, JN | 1 |
1 other study available for 3,4-methylenedioxyamphetamine and Brain Neoplasms
Article | Year |
---|---|
Food Is Love: Partnering With Families to Provide Nourishment at the End of Life.
Topics: Administration, Cutaneous; Brain Neoplasms; Death; Fluid Therapy; Grief; Humans; Love; Massage; Moth | 2020 |